as 03-28-2025 4:00pm EST
Deluxe Corporation is principally a payments and data company. Its reportable segments are; Merchant Services, B2B Payments, Data Solutions, and Print. Maximum revenue is derived from its Print segment which provides printed personal and business checks, business essentials, as well as branded promotional, print, apparel, and digital storefront solutions. The Merchant Services segment provides electronic credit and debit card authorization, payment systems, and processing services. The B2B segment offers treasury management solutions, integrated accounts payable disbursements, and fraud and security services, and the Data Solutions segment offers data, analytics, and marketing services as well as financial institution profitability reporting and business incorporation services.
Founded: | 1915 | Country: | United States |
Employees: | N/A | City: | MINNEAPOLIS |
Market Cap: | 709.6M | IPO Year: | N/A |
Target Price: | $31.00 | AVG Volume (30 days): | 361.7K |
Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 1.18 | EPS Growth: | 99.86 |
52 Week Low/High: | $15.13 - $24.87 | Next Earning Date: | 04-30-2025 |
Revenue: | $2,121,761,000 | Revenue Growth: | -3.22% |
Revenue Growth (this year): | 0.86% | Revenue Growth (next year): | 1.12% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Zint William C | DLX | SVP, Chief Financial Officer | Mar 12 '25 | Buy | $15.95 | 175 | $2,791.25 | 21,902 |
DLX Breaking Stock News: Dive into DLX Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
Business Wire
4 days ago
Simply Wall St.
8 days ago
ACCESS Newswire
11 days ago
Business Wire
17 days ago
Argus Research
25 days ago
Simply Wall St.
a month ago
Argus Research
a month ago
The information presented on this page, "DLX Deluxe Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.